tqh2722
mAbexperimental
Clinical trial activity
6 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
5
Phase 3
1
Phase 4
0
Earliest trial started Jun 30, 2022 (NCT05409326)
Timeline
Indications
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06760182 | Phase 2 | Mar 10, 2025 | Government of China |
| NCT06552520 | Phase 3 | Sep 30, 2024 | Government of China |
| NCT06439381 | Phase 2 | Jul 16, 2024 | Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd |
| NCT06089278 | Phase 2 | Nov 30, 2023 | Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd |
| NCT05970432 | Phase 2 | Jun 19, 2023 | Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd |
| NCT05409326 | Phase 1 | Jun 30, 2022 | Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd |
Showing 6 of 6 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd | For profit | 4 | 4 | 2 | 2022 |
| Government of China | Government | 2 | 2 | 2 | 2024 |
2 organizations
Page 1 / 1